Varian completes buy of ACCEL Instruments
Varian Medical Systems announced it has successfully completed the acquisition of ACCEL Instruments GmbH, a privately-held supplier of scientific research instruments and proton therapy systems for cancer treatment based near Cologne, Germany. The deal totaled $30 million.
"We are pleased to add this promising new business to our growth portfolio," said Tim Guertin, president and CEO, Varian Medical Systems. "With ACCEL Instruments, we have the opportunity to build a several hundred million dollar business based on improving cancer care with a clinically practical and affordable system for proton therapy."
ACCEL has approximately $30 million in annual revenues and employs about 250 employees. The business will report to Varian Vice President Lester Boeh, who is responsible for managing Varian's portfolio of emerging businesses.
"We are pleased to add this promising new business to our growth portfolio," said Tim Guertin, president and CEO, Varian Medical Systems. "With ACCEL Instruments, we have the opportunity to build a several hundred million dollar business based on improving cancer care with a clinically practical and affordable system for proton therapy."
ACCEL has approximately $30 million in annual revenues and employs about 250 employees. The business will report to Varian Vice President Lester Boeh, who is responsible for managing Varian's portfolio of emerging businesses.